KimberI., AgiusR., BasketterD.A., CorsiniE., CullinanP., DearmanR.J., Gimenez-ArnauE., GreenwellL., HartungT., KuperF., MaestrelliP., RoggenE. & RovidaC. (2007). Chemical respiratory allergy: opportunities for hazard identification and characterisation. The report and recommendations of ECVAM Workshop 60. ATLA35, 243–265.
2.
JarvisJ., SeedM.J., EltonR.A., SawyerL. & AgiusR.M. (2005). The relationship between chemical structure and occupational asthma hazard of low molecular weight organic compunds. Occupational & Environmental Medicine62, 243–250.
3.
HopkinsJ.E., NaisbittD.J., KitteringhamN.R., Dear manR.J., KimberI. & ParkB.K. (2005). Selective haptenation of cellular or extracellular protein by chemical allergens: association with cytokine production. Chemical Research in Toxicology18, 375–381.
4.
GerberickG.F., VassaloJ.D., BaileyR.E., ChaneyJ.G., MorrallS.W. & LepoittevinJ.P. (2004). Development of a peptide reactivity assay for screening contact allergens. Toxicological Sciences81, 332–343.
5.
ToebakM.M., MoedH., von BlombergM.B., BruynzeelD.P., GibbsS., ScheperR.J. & RustemeyerT. (2006). Intrinsic characteristics of contact and respiratory allergens influence production of polarizing cytokines by dendritic cells. Contact Dermatitis55, 238–245.
6.
BoverhofD.R., BillingtonR., GollapudiB.B., HotchkissJ.A., KriegerS.M., PooleA., WiescinskiC.M. & WoolhiserM.R. (2008). Respiratory sensitization and allergy: current research approaches and needs. Toxicology & Applied Pharmacology226, 1–13.
7.
IsolaD., KimberI., SarloK., LalkoJ. & SipesI.G. (2008). Chemical respiratory allergy and occupational asthma: what are the key areas of uncertainty?Journal of Applied Toxicology28, 249–253.
8.
DupuisG. & BenezraC. (1982). Allergic Contact Dermatitis to Simple Chemicals: A Molecular Approach, 183pp. New York, NY, USA:Marcel Dekker.
RegalJ.F., MohrmanM.E. & SailstadD.M. (2001). Trimellitic anhydride-induced eosinophilia in a mouse model of occupational asthma. Toxicology & Applied Pharmacology175, 234–242.
11.
MathesonJ.M., JohnsonV.J. & LusterM.I. (2005). Immune mediators in a murine model for occupational asthma: Studies with toluene diisocyanate. Toxicological Sciences84, 99–109.
12.
ZhangX.D., FedanJ.S., LewisD.M. & SiegelP.D. (2004). Asthma-like biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride powder. Journal of Allergy & Clinical Immunology113, 320–326.
13.
FarrajA.K., BoykinE., Haykal-CoatesN., GavettS.H., DoerflerD. & SelgradeM. (2007). Th2 cytokines in skin draining lymph nodes and serum IgE do not predict airway hypersensitivity to intranasal isocyanate exposure in mice. Toxicological Sciences100, 99–108.
14.
SelgradeM., BoykinE.H., Haykal-CoatesN., WoolhiserM.R., WiescinskiC., AndrewsD.L., FarrajA.K., DoerflerD.L. & GavettS.H. (2006). Inconsistencies between cytokine profiles, antibody responses, and respiratory hyperresponsiveness following dermal exposure to isocyanates. Toxicological Sciences94, 108–117.
15.
DearmanR.J., FilbyA., HumphreysI.R. & KimberI. (2002). Interleukins 5 and 13 characterise immune responses to respiratory sensitising acid anhydrides. Journal of Applied Toxicology22, 317–325.
16.
SastreJ., VandenplasO. & ParkH.S. (2003). Pathogenesis of occupational asthma. European Respiratory Journal22, 364–373.
17.
PronkA., PrellerL., Raulf-HeimsothM., JonkersI.C.L., LammersJ.W., WoutersI.M., DoekesG., WisnewskiA.V. & HeederikD. (2007). Respiratory symptoms, sensitization, and exposure-response relationships in spray painters exposed to isocyanates. American Journal of Respiratory & Critical Care Medicine176, 1090–1097.
18.
ZeissC.R., LevitzD., ChaconR., WolkonskyP., PattersonR. & PruzanskyJ.J. (1980). Quantitation and new antigenic determinant specificity of antibodies induced by inhalation of trimellitic anhydride in man. International Archives of Allergy & Applied Immunology61, 380–388.
19.
OttM.G., JollyA.T., BurkertA.L. & BrownW.E. (2007). Issues in diisocyanate antibody testing. Critical Reviews in Toxicology37, 567–585.
20.
FarrajA.K., HarkemaJ.R. & KaminskiN.E. (2004). Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice. Toxicological Sciences79, 315–325.
21.
RessmeyerA.R., LarssonA.K., VollmerE., DahlènS.E., UhligS. & MartinC. (2006). Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. European Respiratory Journal28, 603–611.
22.
WenzelS. & HolgateS.T. (2006). The mouse trap: It still yields few answers in asthma. American Journal of Respiratory & Critical Care Medicine174, 1173–1176.
23.
FinkelmanF.D. & Wills-KarpM. (2008). Usefulness and optimization of mouse models of allergic airway disease. Journal of Allergy Clinical Immunology121, 603–606.
24.
DearmanR.J. & KimberI. (2003). Factors influencing the induction phase of skin sensitization. American Journal of Contact Dermatitis14, 188–194.
25.
KimberI. & DearmanR.J. (2005). What makes a chemical a respiratory sensitizer?Current Opinion in Allergy & Clinical Immunology5, 119–124.
26.
GerberickG.F., VassaloJ.D., FoerstschL.M., PriceB.B., ChaneyJ.D. & LepoittevinJ.P. (2007). Quantification of chemical peptide reactivity assay for screening contact allergens: a classification tree model approach. Toxicological Sciences97, 417–427.
27.
RotheH., SarloK., GerberickG.F., FoertschL., DearmanR.J. & KimberI. (2008). Evaluation of respiratory chemical allergens in the peptide reactivity assay. The Toxicologist102, 296.
28.
AebyP., PythonF. & GoebelC. (2007). Skin sensitization: Understanding the in vivo situation for the development of reliable in vitro test approaches. ALTEX24, 3–5.
29.
NevesB.M., CruzM.T., FranciscoV., GoncaloM., FigueiredoA., DuarteC.B. & LopesM.C. (2008). Differential modulation of CXCR4 and CD40 protein levels by skin sensitizers and irritants in the FSDC cell line. Toxicology Letters177, 74–82.
30.
ToebakM.M., PohlmannP.R., Sampat-SardjoepersadS.C., von BlombergM.B., BruynzeelD.P., ScheperR.J., RustemeyerT. & GibbsS. (2006). CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicology in Vitro20, 117–124.
31.
SchreinerM., PeiserM., BriechleD., StahlmannR., ZuberbierT. & WannerR. (2007). A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential. Allergy62, 1419–1428.
32.
LimY.M., MoonS.J., AnS.S., LeeS.J., KimS.Y., ChangI.S., ParkK.L., KimH.A. & HeoY. (2008). Suitability of macrophage inflammatory protein-1β production by THP-1 cells in differentiating skin sensitizers from irritant chemicals. Contact Dermatitis58, 193–198.
33.
SakaguchiH., AshikagaT., MiyazawaM., YoshidaY., ItoY., YoneyamaK., HirotaM., ItagakiH., ToyodaH. & SuzukiH. (2006). Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II: An inter-laboratory study of the h-CLAT. Toxicology in Vitro20, 774–784.
34.
SakaguchiH., AshikagaT., MiyazawaM., KosakaN., ItoY., YoneyamaK., SonoS., ItagakiH., ToyodaH. & SuzukiH. (2008). The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test — human cell line activation test (h-CLAT). Cell Biology & Toxicology, in press.
35.
SchoetersE., VerheyenG.R., NelissenI., Van RompayE.R., HooybergsJ., Van Den HeuvelR.V., WittersH., SchoetersG.E., Van TendelooV.F. & BernemanZ.N. (2007). Microarray analyses in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. Molecular Immunology44, 3222–3233.
36.
SzameitS., VierlingerK., FarmerL., TuschlH. & NoehammerC. (2008). Microarray-based in vitro test system for the discrimination of contact allergens and irritants: identification of potential marker genes. Clinical Chemistry54, 525–533.
37.
Cluzel-TailhardatM., Bonnet-DuquennoyM., de QueralD.P., VocansonM., KurfurstR., CourtellemontP., Le VarletB. & NicolasJ.F. (2007). Chemicals with weak skin sensitizing properties can be identified using low-density microarrays on immature dendritic cells. Toxicology Letters174, 98–109.
38.
GildeaL.A., RyanC.A., FoerrtschL.M., KennedyJ.M., DearmanR.J., KimberI. & GerberickG.F. (2006). Identification of gene expression changes induced by chemical allergens in dendritic cells: opportunities for skin sensitization testing. Journal of Investigative Dermatology126, 1813–1822.
39.
MastersonA.J., SombroekC.C., de GruijlT.D., GrausY.M.F., van der VlietH.J.J., LougheedS.M., van den EertweghA.J.M., PinedoH.M. & SchepersR.J. (2002). MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34+ precursors. Blood100, 701–703.
40.
BallsM. & HellstenE. (2000). Statement on the validity of the local lymph node assay for skin sensitisation testing. ATLA28, 366–367.
41.
NIH (1999). The Murine Local Lymph Node Assay. The Results of an Independent Peer Review Evaluation Coordinated By the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program Center for the Evaluation of Alternative Toxicological Methods (NICEATM). NIH Publication No. 99-4494, 211pp. Research Triangle Park, NC, USA:National Toxicology Program.
42.
GerberickG.F., RyanC.A., KernP.S., SchlatterH., DearmanR.J., KimberI., PatlewiczG. & BasketterD.A. (2005). Compilation of historical local lymph node assay data for the evaluation of skin sensitization alternatives. Dermatitis16, 157–202.
43.
KimberI., DearmanR.J., BettsC.J., RyanC.A., KernP.S., PatlewiczG.Y. & BasketterD.A. (2006). The local lymph node assay and skin sensitization: a cut-down screen to reduce animal requirements?Contact Dermatitis54, 181–185.
44.
KimberI., CumberbatchM., DearmanR.J., BhushanM. & GriffithsC.E.M. (2000). Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilisation. British Journal of Dermatology142, 401–412.
45.
RoggenE.L., LindstedtM., BorrebaeckC. & VerheyenG.R. (2006). Interactions between dendritic cells and epithelial cells in allergic disease. Toxicology Letters162, 71–82.
46.
RoggenE.L., KristensenN. & VerheyenG.R. (2006). Respiratory immunotoxicity: An in vitro assessment. Toxicology in Vitro20, 1249–1264.
47.
FujiiS., LiuK., SmithC., BonitoA.J., & SteinmanR.M. (2004). The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. Journal of Experimental Medicine199, 1607–1618.
48.
StoyN. (2001). Macrophage biology and pathobiology in the evolution of immune responses: a functional analysis. Pathobiology69, 179–211.
49.
ChenC.L., LeeC.T., LiuY.C., WangJ.Y., LeiH.Y. & YuC.K. (2003). House dust mite Dermatophagoides farinae augments proinflammatory mediator production and accessory function of alveolar macrophages: implications for allergic sensitisation and inflammation. Journal of Immunology170, 528–536.
50.
RadyukS., MerickoP.A., PopovaT.G., GreneE. & AlibekK. (2003). In vitro-generated respiratory mucosa: a new tool to study inhalation anthrax. Biochemical & Biophysical Research Communications305, 624–632.
51.
RoggenE.L. (2008). Models for prediction of immunogenicity. In Immunogenicity of Biopharmaceuticals (ed. van de WeertM. & MoellerE.H.), pp. 75–95. New York, NY, USA:Springer.